Scandinavian ChemoTech (Sweden) Top Management
CMOTEC-B | SEK 1.20 0.09 6.98% |
Scandinavian ChemoTech employs about 6 people. The company is managed by 5 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.2 employees per reported executive. Analysis of Scandinavian ChemoTech's management performance can provide insight into the company performance.
Stefan Frick Insider CEO Founder |
Jonathan Furelid Insider Head relation |
Scandinavian |
Scandinavian ChemoTech Management Team Effectiveness
The company has return on total asset (ROA) of (0.5117) % which means that it has lost $0.5117 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1711) %, meaning that it generated substantial loss on money invested by shareholders. Scandinavian ChemoTech's management efficiency ratios could be used to measure how well Scandinavian ChemoTech manages its routine affairs as well as how well it operates its assets and liabilities.Scandinavian ChemoTech Workforce Comparison
Scandinavian ChemoTech AB is rated third in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 85.0. Scandinavian ChemoTech holds roughly 6.0 in number of employees claiming about 7% of stocks in Biotechnology industry.
Scandinavian ChemoTech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Scandinavian ChemoTech Price Series Summation is a cross summation of Scandinavian ChemoTech price series and its benchmark/peer.
Scandinavian ChemoTech Notable Stakeholders
A Scandinavian ChemoTech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Scandinavian ChemoTech often face trade-offs trying to please all of them. Scandinavian ChemoTech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Scandinavian ChemoTech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stefan Frick | CEO Founder | Profile | |
Jonathan Furelid | Head relation | Profile | |
Prabhat Rastogi | Chief India | Profile | |
Ann Ohlsson | Head Fin | Profile | |
Suhail Mufti | Local Director | Profile |
About Scandinavian ChemoTech Management Performance
The success or failure of an entity such as Scandinavian ChemoTech often depends on how effective the management is. Scandinavian ChemoTech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Scandinavian management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Scandinavian management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Scandinavian ChemoTech AB provides cancer care and pain management solutions. Scandinavian ChemoTech AB is headquartered in Malmo, Sweden. Scandinavian ChemoTech is traded on Stockholm Stock Exchange in Sweden.
Please note, the presentation of Scandinavian ChemoTech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Scandinavian ChemoTech's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Scandinavian ChemoTech's management manipulating its earnings.
Scandinavian ChemoTech Workforce Analysis
Traditionally, organizations such as Scandinavian ChemoTech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Scandinavian ChemoTech within its industry.Scandinavian ChemoTech Manpower Efficiency
Return on Scandinavian ChemoTech Manpower
Revenue Per Employee | 8.2K | |
Revenue Per Executive | 9.8K | |
Net Loss Per Employee | 3M | |
Net Loss Per Executive | 3.5M |
Complementary Tools for Scandinavian Stock analysis
When running Scandinavian ChemoTech's price analysis, check to measure Scandinavian ChemoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scandinavian ChemoTech is operating at the current time. Most of Scandinavian ChemoTech's value examination focuses on studying past and present price action to predict the probability of Scandinavian ChemoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scandinavian ChemoTech's price. Additionally, you may evaluate how the addition of Scandinavian ChemoTech to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |